Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Muraro

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
International Review of Cell and Molecular Biology|September 22, 2023
Circulating tumor cells and host immunity: A tricky liaisonElena Muraro, Giulia Brisotto
Human Vaccines & Immunotherapeutics|February 15, 2013
Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomasElena Muraro, Debora Martorelli, Riccardo Dolcetti
Methods in Molecular Biology (Clifton, N.J.)|May 22, 2025
Evaluation of NF-kB Nuclear Translocation in Natural Killer Cells by Imaging Multispectral Flow Cytometry as a Marker of Anticancer Immune ActivationGiulia Brisotto, Raja Dhibi, Jessica Dal Col, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2011
Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cellsDebora Martorelli, Giuseppe Coppotelli, Elena Muraro, et al.
International Reviews of Immunology|July 20, 2010
Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancerDebora Martorelli, Elena Muraro, Anna Merlo, et al.
Cancers|November 27, 2021
<sup>1</sup>H-NMR Plasma Lipoproteins Profile Analysis Reveals Lipid Metabolism Alterations in HER2-Positive Breast Cancer PatientsGiuseppe Corona, Emanuela Di Gregorio, Alessia Vignoli, et al.
Haematologica|April 28, 2010
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersAnna Merlo, Riccardo Turrini, Riccardo Dolcetti, et al.
Cancers|May 13, 2023
Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint InhibitorsElena Muraro, Lorenzo Vinante, Elisabetta Fratta, et al.
Current Cancer Drug Targets|November 11, 2010
Cancer vaccines in phase II/III clinical trials: state of the art and future perspectivesSara Cecco, Elena Muraro, Elisa Giacomin, et al.
Clinical & Developmental Immunology|February 10, 2012
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersDebora Martorelli, Elena Muraro, Anna Merlo, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
International Review of Cell and Molecular Biology|September 22, 2023
Circulating tumor cells and host immunity: A tricky liaisonElena Muraro, Giulia Brisotto
Human Vaccines & Immunotherapeutics|February 15, 2013
Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomasElena Muraro, Debora Martorelli, Riccardo Dolcetti
Methods in Molecular Biology (Clifton, N.J.)|May 22, 2025
Evaluation of NF-kB Nuclear Translocation in Natural Killer Cells by Imaging Multispectral Flow Cytometry as a Marker of Anticancer Immune ActivationGiulia Brisotto, Raja Dhibi, Jessica Dal Col, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2011
Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cellsDebora Martorelli, Giuseppe Coppotelli, Elena Muraro, et al.
International Reviews of Immunology|July 20, 2010
Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancerDebora Martorelli, Elena Muraro, Anna Merlo, et al.
Cancers|November 27, 2021
<sup>1</sup>H-NMR Plasma Lipoproteins Profile Analysis Reveals Lipid Metabolism Alterations in HER2-Positive Breast Cancer PatientsGiuseppe Corona, Emanuela Di Gregorio, Alessia Vignoli, et al.
Haematologica|April 28, 2010
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersAnna Merlo, Riccardo Turrini, Riccardo Dolcetti, et al.
Cancers|May 13, 2023
Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint InhibitorsElena Muraro, Lorenzo Vinante, Elisabetta Fratta, et al.
Current Cancer Drug Targets|November 11, 2010
Cancer vaccines in phase II/III clinical trials: state of the art and future perspectivesSara Cecco, Elena Muraro, Elisa Giacomin, et al.
Clinical & Developmental Immunology|February 10, 2012
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersDebora Martorelli, Elena Muraro, Anna Merlo, et al.
Pageof 5